A couple of interesting points in this presentation
- • 1Q FY21 on track to report sales growth of +25% above 4Q FY20
- Can now sell to select customers in the US under a section lVc exemption until FDA EUA is received
- Targeting first US customer contract for SARS-COV2 product
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $95.39M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 7860 | 1 |
View Market Depth
| Last trade - 09.59am 22/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |
Day chart unavailable